Publications by authors named "Dainius Balis"

Claim this Profile
E
Effects of canagliflozin on serum potassium in the CANagliflozin cardioVascular Assessment Study (CANVAS) Program.
Matthew R Weir, April Slee, Tao Sun, Dainius Balis, Richard Oh

Clin Kidney J· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal safety of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus.
Mehul Desai, Yshai Yavin, Dainius Balis, Don Sun, John Xie

Diabetes Obes Metab· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longer-term safety and tolerability of canagliflozin in patients with type 2 diabetes: a pooled analysis.
Rong Qiu, Dainius Balis, John Xie, Michael J Davies, Mehul Desai

Curr Med Res Opin· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects.
Hiddo J L Heerspink, Mehul Desai, Meg Jardine, Dainius Balis, Gary Meininger

J Am Soc Nephrol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome.
Michael J Davies, Katherine W Merton, Ujjwala Vijapurkar, Dainius A Balis, Mehul Desai

Diabetes Metab Syndr Obes· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canagliflozin: Efficacy and Safety in Combination with Metformin Alone or with Other Antihyperglycemic Agents in Type 2 Diabetes.
Rong Qiu, Dainius Balis, George Capuano, John Xie, Gary Meininger

Diabetes Ther· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canagliflozin: a sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes mellitus.
Norm Rosenthal, Gary Meininger, Kirk Ways, David Polidori, Mehul Desai, Dainius Balis

Ann N Y Acad Sci· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canagliflozin provides durable glycemic improvements and body weight reduction over 104 weeks versus glimepiride in patients with type 2 diabetes on metformin: a randomized, double-blind, phase 3 study.
Lawrence A Leiter, Kun-Ho Yoon, Pablo Arias, Gisle Langslet, John Xie, Dainius A Balis

Diabetes Care· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, on measurement of serum 1,5-anhydroglucitol.
Dainius A Balis, Cindy Tong, Gary Meininger

J Diabetes· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of musculoskeletal toxicity 5 years after therapy with levofloxacin.
John S Bradley, Ralph E Kauffman, Dainius A Balis, Ciaran M Duffy, Peter G Gerbino

Pediatrics· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial.
William T Cefalu, Lawrence A Leiter, Kun-Ho Yoon, Pablo Arias, Leo Niskanen, Dainius A Balis

Lancet· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation.
Susan C Nicholson, Tobias Welte, Thomas M File, Richard S Strauss, Bart Michiels, Dainius Balis

Int J Antimicrob Agents· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of continuous venovenous hemofiltration and continuous venovenous hemodiafiltration on the disposition of doripenem.
Iolanda Cirillo, Nicole Vaccaro, Dainius Balis, Rebecca Redman, Gary R Matzke

Antimicrob Agents Chemother· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media.
Gary J Noel, Jeffrey L Blumer, Michael E Pichichero, James A Hedrick, Richard H Schwartz, Dainius A Balis

Pediatr Infect Dis J· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders.
Gary J Noel, John S Bradley, Ralph E Kauffman, Ciaran M Duffy, Peter G Gerbino, Dainius A Balis

Pediatr Infect Dis J· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis